In 2007, the next-generation sequencing technologies have come into their own with an impressive array of successful applications. Kelly Rae Chi reports.

Technologies that are based on next-generation sequencing are increasingly being used to study individual cells. The authors discuss the application of this approach to single-cell genomics and ...

Sequencing a patient’s cancer provides insights into many facets of tumor biology. These include features acquired as somatic alterations by the cancer clone, such as driver mutations, large ...

Advances in DNA sequencing have facilitated a change in the method used to screen for fetal chromosome trisomies. This review describes the basis and development of the method.

Molecular biomarkers informing disease diagnosis, prognosis, and treatment decisions in patients with breast cancer are being uncovered by next-generation sequencing (NGS) technologies. In this study, ...

At the Nevada Genomics Center we offer DNA sequencing using dye-terminator Sanger sequencing with analysis on an Applied Biosystems SeqStudio Genetic Analyzer. A Sanger sequencing reaction is run with ...

Sequencing of Immunotherapies in Multiple Myeloma Considering the recent approvals and ongoing development of multiple TCE therapies, rational sequencing of combination approaches holds great promise ...

Illumina Inc and BGI Group's MGI Tech Co and Complete Genomics have settled U.S. litigation over their rival DNA-sequencing technology, the companies said Thursday.

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs.

Quantum-Si, the pioneer in Next-Generation Protein Sequencing (NGPS™) will feature groundbreaking research through one company-led poster and two customer-led posters highlighting the ...

Their findings, published in the Proceedings of the National Academy of Sciences, pave the way for solid-state, label-free DNA sequencing technologies with implications for precision medicine.

Recently, the field has moved toward next-generation sequencing (NGS), which addresses limitations of current testing strategies, including cell culture and PCR assays.